Health know-how firm, Buddy Healthcare has concluded a funding spherical of €2 million to develop its automated care coordination platform BuddyCare.
This newest funding spherical is led by UTU Invest Oy and Swedish funding firm Nidoco AB, a subsidiary of Virala Oy Ab owned by Alexander and Albert Ehrnrooth. Former shareholders equivalent to Spartamed Oy, led by doctor investor Ali Omar, additionally took half within the funding spherical.
Buddy Healthcare may also obtain funding from Business Finland, after having been chosen as a part of their Young Innovative Company (NIY) funding programme, an initiative that goals to speed up the worldwide progress of Finnish startups with promising potential.
WHY IT MATTERS
The BuddyCare platform automates the very important job of instructing and getting ready sufferers for his or her remedy, a course of that’s normally accomplished by way of mail or cellphone.
By automating this technique, the platform reduces time wanted by healthcare professionals for his or her care coordination, releasing up time to ship care the place most wanted. The platform additionally collects medical historical past from sufferers, additional supporting healthcare professionals in making remedy suggestions.
The care pathway is seen on the BuddyCare App for the affected person and includes a timeline that comprises all the knowledge and conditions required. Based on their private care schedule, the affected person receives notifications for upcoming duties and is ready to ship messages to the healthcare skilled or e-book a video appointment via the app if wanted.
Commenting on the corporate’s plans to increase its footprint, Jussi Määttä, CEO of Buddy Healthcare, mentioned: “The digitalisation of healthcare has made an excellent leap ahead in Finland within the latest years.The demand for digital affected person and care coordination programs has elevated each in Finland and extra broadly in Europe. Our platform could be very aggressive within the European market. We are already working in 12 hospitals in Finland and in three hospitals in Germany. Implementation processes are additionally in progress in three different EU international locations.”
THE LARGER CONTEXT
Meanwhile, in one other transfer to present sufferers the chance to be extra concerned of their care, Novartis UK and Cievert recently announced a digital innovation partnership to assist affected person care in rheumatology and dermatology by capturing patient-reported knowledge.
ON THE RECORD
Määttä mentioned: “The new capital goes for use to speed up gross sales, particularly in Germany and the UK. The urgency for automation is extra urgent than ever as a result of COVID-19 disaster. For instance, in Germany the federal government has already earmarked €4 billion to assist the digitalisation of hospitals.”
Patrick Castrén, CEO of Nidoco AB mentioned: “The purpose for the funding is the pattern of course of optimisation enabled by healthcare digitalisation, which advantages sufferers, hospitals and different service suppliers alike. Buddy Healthcare gives a product that’s extremely aggressive, even within the international market, in addition to a group filled with engaged and skilled professionals.”